MedTrace Logo

Surgery and Neuroablative Procedures in Spasticity

NCT04670783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 63

Last updated 2023-06-05

No results posted yet for this study

Summary

For many patients with spasticity, traditional therapies have not achieved maximal outcomes. Due to common complaints such as pain, limb positioning and hygiene concerns, there has been an increase demand for other adjunctive therapies like surgeries and other interventions. This spasticity multidisciplinary clinic consisting of a physiatrist, plastic surgeon and anesthesiologist is performing a novel approach to refractory spasticity to triage and designed a treatment plan for them as routine medical care. This study will document the efficacy of this novel designed multidisciplinary approaches for intervention in complex spasticity patients, and will develop a decision-making algorithm in spasticity including both traditional treatment (i.e. botulinum toxin , bracing) and novel treatments(i.e. neurectomy , cryoneurotomy).

Conditions

  • Upper Extermity Spasticity
  • Multidisciplinary Approach
  • Novel Algorithm
  • Diagnostic Nerve Block
  • Surgery
  • Percutaneous Neuroablative Procedures
  • Refractory Spasticity

Interventions

PROCEDURE

Surgery

Orthopedic surgery (i.e. tenotomy, tendon transfer) or percutaneous neuroablative procedures (i.e. cryoneurotomy) which will be done for upper limb refractory spasticity after being triaged by DNB.

Sponsors & Collaborators

  • Vancouver Island Health Authority

    lead OTHER

Principal Investigators

  • Paul Winston, MD FRCPC · VIHA

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2023-05-30
Completion
2023-05-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04670783 on ClinicalTrials.gov